IL17A and inflammation: Meanwhile, IL-17A inhibition produced regression of atherosclerosis with lower expression of the chemokines, proinflammatory cytokines, and adhesion molecules, suggesting a modulatory role of IL-17A in vascular inflammation and related atherosclerosis [36].